DYNE THERAPEUTICS INC
DYN
Health Care
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Dyne Therapeutics is a biotechnology company developing therapeutics for genetically driven muscle diseases. Its lead programs utilize antibody-oligonucleotide conjugates to deliver genetic medicines to muscle tissue. The development of these novel therapeutics requires preclinical testing in animal models, a standard industry practice for assessing safety and efficacy prior to human clinical trials.
The company’s research and development activities inherently involve animal testing. Preclinical studies for its programs targeting myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD), and facioscapulohumeral muscular dystrophy (FSHD) rely on data generated from animal studies to support regulatory filings and clinical advancement. This places the company’s core business model within the scope of commercial animal exploitation for research and development purposes.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.